← FDA Drug Approvals (Drugs@FDA)

IRINOTECAN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EMCURE PHARMS LTD · Approved 2012-02-14

Drug application

FDA Application #

ANDA200771

Application type

Abbreviated New Drug Application (Generic)

Brand name

IRINOTECAN HYDROCHLORIDE

Generic name

Irinotecan Hydrochloride

Active ingredients

IRINOTECAN HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

EMCURE PHARMS LTD

First approval

2012-02-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown